SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (8366)5/22/1998 5:17:00 PM
From: Paul Tran  Read Replies (1) | Respond to of 23519
 
PFE is more diversified and big.
So Viagra effect may not bring it down much. But it will
create a more positive effect on VVUS.

VVUS is a pure player in this erection.
VVUS is beaten down, look at the chart.
Expecting a more positive release from VVUS Investor Relation.
With more bad press coverage on PFE, VVUS will get more attention.
VVUS just got South Africa and Sweden approval.
VVUS got 50% short interest.
FDA will not close the chapter on these 6 deaths soon. It will drag on. As they drag on to approve any drugs.

VVUS sounds much better as I keep thinking about it.



To: VLAD who wrote (8366)5/22/1998 7:33:00 PM
From: Andrew H  Read Replies (1) | Respond to of 23519
 
At first they were saying that only people who took nitro shouldn't take Viagra--latest I heard on CNBC was that people with heart disease should not take it. I wonder how many have died while taking MUSE?

There will most likely be more news coverage this week detrimental to PFE and Viagra. Many, many will be scared away--very likely with good cause.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News